NCT05416034View on ClinicalTrials.gov

Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy

NACompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

July 30, 2018

Study Completion Date

August 31, 2018

Conditions
Spinal Muscular Atrophy Type II
Interventions
DEVICE

Use of the ATLAS 2025 exoskeleton at home

Each participant will use the ATLAS 2025 exoskeleton at their homes, 5 days a week during a period of two months, for walking with the device and performing motor activities in 60 minutes duration sessions..

Trial Locations (1)

28034

Hospital Ramón y Cajal, Madrid

Sponsors

Lead Sponsor

MarsiBionics
All Listed Sponsors
collaborator

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

OTHER

lead

MarsiBionics

INDUSTRY